Clinical Trial Update: Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders

View source ↗

Summary

The NIAID-sponsored clinical trial examining the immunopathogenesis of food allergy and eosinophilic gastrointestinal disorders has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis
• Eosinophilic Gastroenteritis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Eosinophilic Gastroenteritis, Eosinophilic Esophagitis | Status: TERMINATED